Showing results (341-350 of 369) with videos related to

Sort By:
Pageof 37
Carcinogenesis|June 25, 2015
Disruptive chemicals, senescence and immortalityAmancio Carnero, Carmen Blanco-Aparicio, Hiroshi Kondoh, et al.
Carcinogenesis|June 25, 2015
Environmental immune disruptors, inflammation and cancer riskPatricia A Thompson, Mahin Khatami, Carolyn J Baglole, et al.
Familial Cancer|October 24, 2020
Identification and management of Lynch syndrome in the Middle East and North African countries: outcome of a survey in 12 countriesMohammad Sina, Zeinab Ghorbanoghli, Amal Abedrabbo, et al.
Carcinogenesis|June 25, 2015
Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?R Brooks Robey, Judith Weisz, Nancy B Kuemmerle, et al.
Carcinogenesis|June 25, 2015
The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signallingWilhelm Engström, Philippa Darbre, Staffan Eriksson, et al.
Frontiers in Immunology|September 23, 2024
Effect of pioglitazone on inflammatory response and clinical outcome in T2DM patients with COVID-19: a randomized multicenter double-blind clinical trialKhaled Baagar, Thamer Alessa, Mohamed Abu-Farha, et al.
Carcinogenesis|June 25, 2015
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesisZhiwei Hu, Samira A Brooks, Valérian Dormoy, et al.
Oncotarget|October 22, 2021
Correction: Discovery and clinical introduction of first-in-class imipridone ONC201Joshua E Allen, C Leah B Kline, Varun V Prabhu, et al.
Oncotarget|September 8, 2016
Discovery and clinical introduction of first-in-class imipridone ONC201Joshua E Allen, C Leah B Kline, Varun V Prabhu, et al.
Human Mutation|June 19, 2019
The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countriesYael Laitman, Tara M Friebel, Drakoulis Yannoukakos, et al.
Pageof 37